California, Minnesota, Wisconsin Join FTC Suit To Stop Amgen $27.8B Deal To Buy Horizon Therapeutics -
Portfolio Pulse from Benzinga Newsdesk
California, Minnesota, and Wisconsin have joined the FTC lawsuit to stop Amgen's $27.8 billion acquisition of Horizon Therapeutics, according to a Reuters report citing a court filing.
June 22, 2023 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amgen's $27.8 billion acquisition of Horizon Therapeutics faces opposition as California, Minnesota, and Wisconsin join the FTC lawsuit to stop the deal.
The addition of three states to the FTC lawsuit increases the legal pressure on Amgen's acquisition of Horizon Therapeutics. This could delay or even prevent the deal from going through, potentially impacting Amgen's stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Horizon Therapeutics' $27.8 billion acquisition by Amgen is under threat as California, Minnesota, and Wisconsin join the FTC lawsuit to stop the deal.
The increased legal pressure from the addition of three states to the FTC lawsuit could delay or prevent the acquisition of Horizon Therapeutics by Amgen. This uncertainty may negatively impact Horizon Therapeutics' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100